Point of care detection of respiratory viruses
呼吸道病毒的护理点检测
基本信息
- 批准号:7674353
- 负责人:
- 金额:$ 30万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2009
- 资助国家:美国
- 起止时间:2009-04-15 至 2011-03-31
- 项目状态:已结题
- 来源:
- 关键词:AddressAntibodiesBK VirusBacteriophagesBedside TestingsChemistryChildClinicClinicalCollaborationsCommunicable DiseasesDNADNA-Directed DNA PolymeraseDetectionDevelopmentDisease OutbreaksEngineeringEnzymesEscherichia coliGoalsHIVHealth Care CostsHome environmentHospitalizationHuman ResourcesImmunocompromised HostInfectionInfectious AgentInfluenzaLateralLibrariesLung diseasesMediatingMethodsModelingMolecularMorbidity - disease rateNational Institute of Allergy and Infectious DiseaseNucleic AcidsNursesOperative Surgical ProceduresOutcomePathogen detectionPatientsPediatric HospitalsPerformancePhasePoint-of-Care SystemsPreparationProductivityProspective StudiesRNA VirusesReagentResearch PersonnelRespiratory Tract InfectionsReverse Transcriptase Polymerase Chain ReactionSamplingSatellite VirusesSensitivity and SpecificityStandardizationSystemTechnologyTestingTrainingViralWorkbasecombatcostdesignimprovedinfluenzavirusinstrumentationinternal controlmicrobialmolecular recognitionmortalitymultiplex detectionpandemic diseasepathogenpoint of carepublic health relevancerespiratory virus
项目摘要
DESCRIPTION (provided by applicant): Respiratory infections are a leading cause of morbidity and mortality and have a dramatic impact on global healthcare costs and productivity. Rapid, simple, and robust point of care (POC) detection methods is crucial to effectively combat these infections. Ideally, these tests should be inexpensive and stable for ambient storage. Current methods of pathogen detection fail as a POC method because they are too slow, too expensive, and/or require expensive instrumentation, storage in freezers or highly trained personnel. Consequently, the etiological agents for respiratory diseases often go unidentified. The goal of this project is to develop and integrate improved chemistries and instrumentation to provide a rapid (30 minutes), reliable POC detection tests at less than $10 per test and that is simple and robust enough for a nurse to perform in the clinic or a patient at home. PUBLIC HEALTH RELEVANCE: Rapid, simple, low cost, robust point of care detection methods is crucial to effectively combat respiratory infections. Ideal points of care tests can be operated and interpreted with limited training in clinics, in the field, in warzones or even at home and will improve patient outcome, reduce costs by reducing inappropriate treatment and hospitalization and will help limit spread of infections.
描述(由申请人提供):呼吸道感染是发病率和死亡率的主要原因,对全球医疗成本和生产力产生巨大影响。快速、简单和强大的床旁检测(POC)方法对于有效对抗这些感染至关重要。理想情况下,这些测试应该是廉价和稳定的环境储存。目前的病原体检测方法不能作为POC方法,因为它们太慢、太昂贵和/或需要昂贵的仪器、在冷冻机中的储存或训练有素的人员。因此,呼吸道疾病的病原体往往无法识别。该项目的目标是开发和集成改进的化学和仪器,以提供快速(30分钟),可靠的POC检测测试,每次测试不到10美元,并且简单而强大,足以让护士在诊所或患者家中进行。公共卫生相关性:快速、简单、低成本、稳健的床旁检测方法对于有效防治呼吸道感染至关重要。理想的护理点测试可以在诊所,实地,战区甚至家中进行有限的培训,并将改善患者的结果,通过减少不适当的治疗和住院来降低成本,并将有助于限制感染的传播。
项目成果
期刊论文数量(1)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
Evaluation of the specificity and sensitivity of a potential rapid influenza screening system.
- DOI:10.1016/j.diagmicrobio.2012.09.005
- 发表时间:2013-01
- 期刊:
- 影响因子:2.9
- 作者:Perez LE;Merrill GA;DeLorenzo RA;Schoenfeld TW;Vats A;Moser MJ
- 通讯作者:Moser MJ
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Thomas William Schoenfeld其他文献
Thomas William Schoenfeld的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Thomas William Schoenfeld', 18)}}的其他基金
Improved DNA Polymerases for Genomic Sequencing
用于基因组测序的改进 DNA 聚合酶
- 批准号:
6583877 - 财政年份:2002
- 资助金额:
$ 30万 - 项目类别:
Improved DNA Polymerases for Genomic Sequencing
用于基因组测序的改进 DNA 聚合酶
- 批准号:
7273109 - 财政年份:2002
- 资助金额:
$ 30万 - 项目类别:
Improved DNA Polymerases for Genomic Sequencing
用于基因组测序的改进 DNA 聚合酶
- 批准号:
7405421 - 财政年份:2002
- 资助金额:
$ 30万 - 项目类别:
相似海外基金
University of Aberdeen and Vertebrate Antibodies Limited KTP 23_24 R1
阿伯丁大学和脊椎动物抗体有限公司 KTP 23_24 R1
- 批准号:
10073243 - 财政年份:2024
- 资助金额:
$ 30万 - 项目类别:
Knowledge Transfer Partnership
Role of Natural Antibodies and B1 cells in Fibroproliferative Lung Disease
天然抗体和 B1 细胞在纤维增生性肺病中的作用
- 批准号:
10752129 - 财政年份:2024
- 资助金额:
$ 30万 - 项目类别:
CAREER: Next-generation protease inhibitor discovery with chemically diversified antibodies
职业:利用化学多样化的抗体发现下一代蛋白酶抑制剂
- 批准号:
2339201 - 财政年份:2024
- 资助金额:
$ 30万 - 项目类别:
Continuing Grant
Isolation and characterisation of monoclonal antibodies for the treatment or prevention of antibiotic resistant Acinetobacter baumannii infections
用于治疗或预防抗生素耐药鲍曼不动杆菌感染的单克隆抗体的分离和表征
- 批准号:
MR/Y008693/1 - 财政年份:2024
- 资助金额:
$ 30万 - 项目类别:
Research Grant
Developing first-in-class aggregation-specific antibodies for a severe genetic neurological disease
开发针对严重遗传神经系统疾病的一流聚集特异性抗体
- 批准号:
10076445 - 财政年份:2023
- 资助金额:
$ 30万 - 项目类别:
Grant for R&D
Discovery of novel nodal antibodies in the central nervous system demyelinating diseases and elucidation of the mechanisms through an optic nerve demyelination model
发现中枢神经系统脱髓鞘疾病中的新型节点抗体并通过视神经脱髓鞘模型阐明其机制
- 批准号:
23K14783 - 财政年份:2023
- 资助金额:
$ 30万 - 项目类别:
Grant-in-Aid for Early-Career Scientists
Elucidation of the mechanisms controlling the physicochemical properties and functions of supercharged antibodies and development of their applications
阐明控制超电荷抗体的理化性质和功能的机制及其应用开发
- 批准号:
23KJ0394 - 财政年份:2023
- 资助金额:
$ 30万 - 项目类别:
Grant-in-Aid for JSPS Fellows
Role of antibodies in hepatitis E virus infection
抗体在戊型肝炎病毒感染中的作用
- 批准号:
10639161 - 财政年份:2023
- 资助金额:
$ 30万 - 项目类别:
Defining the protective or pathologic role of antibodies in Post-Ebola Syndrome
定义抗体在埃博拉后综合症中的保护或病理作用
- 批准号:
10752441 - 财政年份:2023
- 资助金额:
$ 30万 - 项目类别:
Human CMV monoclonal antibodies as therapeutics to inhibit virus infection and dissemination
人 CMV 单克隆抗体作为抑制病毒感染和传播的治疗药物
- 批准号:
10867639 - 财政年份:2023
- 资助金额:
$ 30万 - 项目类别: